SCHEMBL4445669

SCHEMBL4445669

CC(C)c1ccc(Cc2[nH]c3ccccc3c2CC(=O)O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPT P10636 3/20 0.53
GAA P10253 2/20 0.53
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53
HPGD P15428 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
TSHR P16473 2/20 0.52
CYP2C19 P33261 2/20 0.52
MTNR1A P48039 2/20 0.52
MTNR1B P49286 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CYP2C9 P11712 1/20 0.52
EGFR P00533 2/20 0.49
CYP2D6 P10635 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2087168 0.87 HPGD (0.61) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL7698484 0.86 MAPT (0.54) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL4262445 0.84 ALDH1A1 (0.55) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL7696486 0.83 ALDH1A1 (0.54) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL8186628 0.83 KDM4E (0.46) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL7692306 0.82 KDM4E (0.56) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL8174978 0.81 ALDH1A1 (0.46) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL8186618 0.81 ALDH1A1 (0.49) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL8178846 0.80 ALDH1A1 (0.47) KDM4EALDH1A1MAPTGAACASP1
SCHEMBL8167639 0.80 MAPT (0.53) KDM4EALDH1A1MAPTGAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134683-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2009-12-23 EP disclosed
WO-2008100867-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2008-08-21 WO disclosed